Morgan Stanley analyst Michael Ulz downgraded AlloVir to Underweight from Equal Weight with a 50c price target.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ALVR:
- Karuna downgraded, Arm target raised: Wall Street’s top analyst calls
- AlloVir downgraded to Underperform from Buy at BofA
- AlloVir downgraded to Equal Weight from Overweight at Morgan Stanley
- AlloVir downgraded to Market Perform from Outperform at Leerink
- Nike downgraded, Waste Management upgraded: Wall Street’s top analyst calls